Canaccord Genuity reiterated their buy rating on shares of Consort Medical plc (LON:CSRT) in a report released on Tuesday morning. Canaccord Genuity currently has a GBX 1,300 ($16.97) target price on the stock.
A number of other research analysts have also issued reports on the stock. Numis Securities Ltd restated an under review rating on shares of Consort Medical plc in a research note on Friday, June 17th. Stifel Nicolaus restated a buy rating and set a GBX 1,200 ($15.66) price target on shares of Consort Medical plc in a research note on Thursday, June 16th. Investec upped their price target on shares of Consort Medical plc from GBX 1,150 ($15.01) to GBX 1,170 ($15.27) and gave the company a buy rating in a research note on Thursday, June 16th. Finally, Panmure Gordon restated a buy rating and set a GBX 1,145 ($14.95) price target on shares of Consort Medical plc in a research note on Thursday, June 16th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock has an average rating of Buy and an average price target of GBX 1,149.67 ($15.01).
Shares of Consort Medical plc (LON:CSRT) opened at 1094.00 on Tuesday. The stock’s 50 day moving average is GBX 1,038.88 and its 200 day moving average is GBX 1,018.22. The company’s market capitalization is GBX 534.19 million. Consort Medical plc has a 12 month low of GBX 904.20 and a 12 month high of GBX 1,155.00.
In other news, insider Cotton,Richard purchased 1,382 shares of the stock in a transaction that occurred on Monday, September 5th. The shares were purchased at an average cost of GBX 651 ($8.50) per share, with a total value of £8,996.82 ($11,743.66).
About Consort Medical plc
Consort Medical plc is a contract development and manufacturing organization (CDMO). The Company is engaged in providing delivery technologies, formulation and manufacturing solutions for drugs. The Company operates through two divisions: Bespak and Aesica. The Bespak division develops and manufactures drug delivery devices to deliver drugs to sufferers of asthma and chronic obstructive pulmonary disease (COPD).
Receive News & Ratings for Consort Medical plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical plc and related companies with MarketBeat.com's FREE daily email newsletter.